We believe that genetic analyses for ABCG5/ABCG8 gene are useful not only to identify carriers of sitosterolemia (patients with hyper LDL cholesterolemia), but also to select the additional therapies for further LDL reduction on top of statins. Here, ABCG8 is linked to sitosterolemia.